AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26308291
Drug: Pro‐En (21
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pro‐En (21 g of leucine‐enriched whey protein with carbohydrate (9 g) and fat (3 g))
Trial: 26308291
Drug: Pro (21
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pro (21 g of leucine‐enriched whey protein without carbohydrate and fat)
Trial: 16595786
Drug: Home care
RxNorm normalized name: Alpha Dent Home Care 0.4% Fluoride Treatment Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home care nurse-directed treatment strategy
Trial: 16595786
Drug: Primary care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primary care physician-directed treatment
Trial: 12411756
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline for 24 h (1 ml/kg/h) beginning 12 h prior to catheterization
Trial: 12411756
Drug: Unrestricted oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unrestricted oral fluids
Trial: 8474062
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) 10 mg im on Day 0, no corticosteroid (Group 1)
Trial: 8474062
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) 10 mg im on Day 0, prednisolone 15 mg/day per os from D-3 (Group 2)
Trial: 8474062
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) 10 mg im on Day 0, long-term prednisolone treatment 15 mg/day (Group 3)
Trial: 23925581
Drug: Complex decongestive
RxNorm normalized name: Qlearquil Nasal Decongestant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complex decongestive physical therapy (CDT) including skin care, manual lymphatic drainage, compression bandages, compression garments, and exercises, n = 15
Trial: 23925581
Drug: Complex decongestive
RxNorm normalized name: Qlearquil Nasal Decongestant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complex decongestive physical therapy (CDT) combined with an intermittent pneumatic compression pump, n = 16
Trial: 23780502
Drug: Montelukast 10
RxNorm normalized name: montelukast 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast 10 mg film-coated tablets
Trial: 30027002
Drug: Montelukast 5
RxNorm normalized name: montelukast 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast 5 mg chewable tablets
Trial: 15582309
Drug: 600-mg loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600-mg loading dose of clopidogrel for 3 to 6 h
Trial: 11179984
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg twice daily + Amoxicillin 750 mg twice daily
Trial: 9067694
Drug: Neoral (microemulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoral (microemulsion oral formulation of cyclosporine A)
Trial: 9067694
Drug: Sandimmune SGC
RxNorm normalized name: Sandimmune
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sandimmune SGC (oral cyclosporine A preparation)
Trial: 8453694
Drug: Cyclophosphamide (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclophosphamide (1.5 g/m2)
Trial: 8453694
Drug: Ifosfamide (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ifosfamide (5 g/m2)
Trial: 3544649
Drug: 0.3 mg
RxNorm normalized name: biotin 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg buprenorphine epidurally
Trial: 3544649
Drug: 0.9 mg
RxNorm normalized name: estradiol 0.9 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9 mg buprenorphine epidurally
Trial: 22101161
Drug: Intravenous ketorolac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ketorolac 15 mg
Trial: 27459533
Drug: Gliclazide (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gliclazide (80 mg twice daily)
Trial: 24825262
Drug: 300,000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300,000 IU of oral vitamin D3 (Group 1; n=38)
Trial: 24825262
Drug: 600,000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600,000 IU of oral vitamin D3 (Group 2; n=38)
Trial: 20616970
Drug: Community-directed intervention
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community-directed intervention (CDI) including vitamin A supplementation, insecticide-treated nets, home management of malaria, and short-course, directly-observed treatment for tuberculosis patients.
Trial: 18396744
Drug: 80 mL
RxNorm normalized name: urinary bag 480 mL MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mL of NaP (two 40 mL doses separated by 24 h)
Trial: 26613214
Drug: Later prophylactic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Later prophylactic INSURE with surfactant administration at the 15th minute after birth
Trial: 23159770
Drug: PegIFNα‐2b (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PegIFNα‐2b (0.5 μg/kg/week)
Trial: 26985045
Drug: Mindfulness meditation
RxNorm normalized name: benzalkonium chloride Topical Foam [Meditize]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness meditation during saline infusion
Trial: 25033643
Drug: Analgesic drug
RxNorm normalized name: ANALGESIC CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Analgesic drug treatment
Trial: 18823760
Drug: Fixed versus
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed versus flexible dose design
Trial: 17922880
Drug: AIR Insulin
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AIR Insulin after 4-week smoking abstinence
Trial: 17922880
Drug: AIR Insulin
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AIR Insulin after smoking one cigarette with NRT
Trial: 1767251
Drug: Phenoxymethylpenicillin dosed
RxNorm normalized name: phenoxymethylpenicillin
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenoxymethylpenicillin dosed twice daily
Trial: 29673262
Drug: Spinal manipulative
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal manipulative therapy with exercise
Trial: 29673262
Drug: Spinal manipulative
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal manipulative therapy without exercise
Trial: 24828024
Drug: Vitamin D₃
RxNorm normalized name: vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D₃ supplementation (20 μg/d)
Trial: 7862896
Drug: 0.8 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.8 g/kg ethanol mixed into a drink of caffeine-free cola
Trial: 31539025
Drug: Preoperative volume
RxNorm normalized name: VOLUME EXPANDERS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative volume replacement therapy (VRT) - 1 ml/kg/h of Hartmann's solution for 12 hours
Trial: 26380441
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (XI mimetic agent, 100 mg/2 mL, by dripping at 5 mg/kg, twice per day for 5 consecutive days)
Trial: 24377214
Drug: Half-needling technique
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half-needling technique combined with moxa stick therapy
Trial: 8425624
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (12 IU/d)
Trial: 28437264
Drug: MgSO4 50
RxNorm normalized name: MgSO4
DrugBank: Magnesium sulfate (DB00653)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: MgSO4 50 mg/kg intravenously for 10 min, followed by a continuous infusion of 15 mg/kg/h during surgery
Trial: 12924170
Drug: Two placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two placebo tablets a day
Trial: 12924170
Drug: One placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One placebo tablet a day
Trial: 21388442
Drug: exenatide 10
RxNorm normalized name: EXENATIDE 10MCG/DOSE 2.4ML 60D PEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: exenatide 10 μg twice daily
Trial: 18513453
Drug: Amoxicillin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (50 mg/kg/d BD)
Trial: 10896693
Drug: Insulin-like growth
RxNorm normalized name: Insulin-like growth factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin-like growth factor I (IGF-I) immunoreactivity in skin of ALS patients
Trial: 8941104
Drug: Carvedilol (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol (n = 133; target dose, 25 to 50 mg BID)
Trial: 1631473
Drug: Various medical
RxNorm normalized name: various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various medical and surgical treatments for endometriosis and medically assisted fertilization (IVF)
Trial: 24100150
Drug: High-dose rate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose rate brachytherapy (HDR-BT) with 2 × 8.5 Gy after external beam radiotherapy (EBRT) of 35.75 Gy in 13 fractions
Trial: 24100150
Drug: Minimum D₉₀
RxNorm normalized name: sipuleucel-T
DrugBank: Sipuleucel-T (DB06688)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minimum D₉₀ of 108% of the prescribed dose
Trial: 16052573
Drug: Cyclophosphamide (CYC),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclophosphamide (CYC), 2 mg/kg/day
Trial: 7857502
Drug: Hypericum extract
RxNorm normalized name: Hypericum extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypericum extract LI 160 (3 x 300 mg daily)
Trial: 7857502
Drug: Imipramine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine (3 x 25 mg daily)
Trial: 25806400
Drug: 300 mcg
RxNorm normalized name: Lymphir 300 MCG Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mcg spinal morphine and 1 gram acetaminophen every 6 hours for 24 hours postoperatively
Trial: 25806400
Drug: 150 mcg
RxNorm normalized name: kelp 150 mcg ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mcg spinal morphine and placebo tablets
Trial: 16088297
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy with Balsamodendron mukul (1.5 g/d) and nifedipine (10 mg/d)
Trial: 2222103
Drug: Cholesterol-lowering agents
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholesterol-lowering agents
Trial: 31571243
Drug: Delayed periodontal
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Delayed periodontal therapy (control group, n=46)
Trial: 28930174
Drug: Capsaicin (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsaicin (4 mg daily)
Trial: 28930174
Drug: Control (0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (0.05 mg daily)
Trial: 25369588
Drug: Multiparametric staining
RxNorm normalized name: fluorexon stain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiparametric staining using CFSE and glycophorin A antibody
Trial: 25369588
Drug: Multiparametric staining
RxNorm normalized name: fluorexon stain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiparametric staining using CFSE, glycophorin A antibody, and annexin V
Trial: 21747355
Drug: Reference atorvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference atorvastatin (RA)
Trial: 21747355
Drug: Generic atorvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Generic atorvastatin (GA)
Trial: 10426160
Drug: Itraconazole 200
RxNorm normalized name: itraconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole 200 mg orally once a day for 4 days
Trial: 29058821
Drug: Ledipasvir (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ledipasvir (120 mg)
Trial: 25875447
Drug: 1.0 g
RxNorm normalized name: IODINE 11.0 g in 1 L TOPICAL SOLUTION [T.D.]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 g dried ginger root powder (morning and afternoon intake)
Trial: 23596262
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of praziquantel (first dose followed by a second dose 2 weeks later)
Trial: 20360498
Drug: Water‐soluble lubricating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water‐soluble lubricating gel alone (control)
Trial: 10793541
Drug: 2% carteolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% carteolol hydrochloride (30 microliters, twice daily for 7 days)
Trial: 21293243
Drug: Carboplatin (AUC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carboplatin (AUC 6) plus Paclitaxel (200 mg/m²) on day 1 (CP)
Trial: 21293243
Drug: Gemcitabine (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine (1000 mg/m²) plus Vinorelbine (25 mg/m²) on days 1 and 8 (GV)
Trial: 8466265
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human erythropoietin (r‐HuEpo) 50 to 150 U administered subcutaneously twice a week from 7 days of age until discharge
Trial: 21557378
Drug: Medication Adherence
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication Adherence Questionnaire (MAQ)
Trial: 29807806
Drug: Drug Attitude
RxNorm normalized name: zinc oxide
DrugBank: Zinc oxide (DB09321)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Drug Attitude Inventory (DAI)
Trial: 17712244
Drug: Fluoxetine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (10 mg/day for the first week and 20 mg/day thereafter)
Trial: 17712244
Drug: Fluoxetine and
RxNorm normalized name: fluoxetine and psycholeptics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine and Placebo (CDRS‐R and MADRS)
Trial: 14733787
Drug: Intra-amniotic administration
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-amniotic administration of pulmonary surfactant (PS)
Trial: 2843722
Drug: Oral testosterone
RxNorm normalized name: testosterone Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral testosterone (200 mg t.i.d.)
Trial: 21632509
Drug: Paclitaxel/carboplatin with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel/carboplatin with PF-3512676 (0.2 mg/kg subcutaneous on days 8 and 15)
Trial: 16393305
Drug: Placebo (without
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (without L. plantarum 299v)
Trial: 15341559
Drug: Calcium (500
RxNorm normalized name: calcium gluconate 45 mg calcium (500 mg) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium (500 mg/d) and vitamin D (400-600 IU/d) supplements
Trial: 11146898
Drug: Once-a-day administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-a-day administration of interferon-alpha
Trial: 8856002
Drug: Fluoxetine, 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine, 20 mg daily
Trial: 9575014
Drug: Fluoxetine and
RxNorm normalized name: fluoxetine and psycholeptics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine and Placebo
Trial: 1627944
Drug: wuzi yanzong
FDA approved: no
EMA approved: no
PMDA approved: no
Description: wuzi yanzong solution (WYS)
Trial: 29370992
Drug: Nivolumab plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nivolumab plus ipilimumab (nivolumab 3 mg/kg plus ipilimumab 1 mg/kg every 3 weeks for four doses, then nivolumab monotherapy)
Trial: 26282726
Drug: Dabigatran 110
RxNorm normalized name: dabigatran 110 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dabigatran 110 mg (D110)
Trial: 26282726
Drug: Dabigatran 150
RxNorm normalized name: dabigatran 150 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dabigatran 150 mg (D150)
Trial: 16085437
Drug: IV paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV paracetamol 2g
Trial: 16085437
Drug: IV paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV paracetamol 1g
Trial: 12823597
Drug: All peginterferon
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All peginterferon alpha‐2a (40 kDa) doses combined
Trial: 6797778
Drug: Non-selective beta-blockade
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-selective beta-blockade (pindolol, 15 mg daily)
Trial: 6797778
Drug: Control (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (4 weeks treatment)
Trial: 23715889
Drug: Hyaluronic acid
RxNorm normalized name: hyaluronic acid
DrugBank: Hyaluronic acid (non-animal stabilized) (DB19175)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyaluronic acid filler (Glytone 1, HA concentration: 14 mg/g)
Trial: 23715889
Drug: Saline physiological
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline physiological solution (control)
Trial: 21482607
Drug: Weekly healthy
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly healthy lifestyle group (intervention)
Trial: 21482607
Drug: Monthly school-readiness
RxNorm normalized name: cetylpyridinium chloride Topical Spray [Rocco's Old School]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly school-readiness group (control)
Trial: 17292880
Drug: Perhexiline pre-treatment
RxNorm normalized name: perhexiline
DrugBank: Perhexiline (DB01074)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perhexiline pre-treatment with Nitroglycerin
Trial: 9621474
Drug: Oxytocin infusion
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin infusion and artificial rupture of membrane (ARM)
Trial: 2646895
Drug: Simvastatin 20
RxNorm normalized name: simvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 20 mg once daily
Trial: 2073672
Drug: Fenofibrate 200
RxNorm normalized name: fenofibrate 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenofibrate 200 mg b.i.d.
Trial: 19033829
Drug: Web-based family
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Web-based family treatment program
Trial: 8825538
Drug: Doxacurium 0.075
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxacurium 0.075 mg.kg‐1 (Group 2)
Trial: 1909485
Drug: Lisuride alone
RxNorm normalized name: lisuride
DrugBank: Lisuride (DB00589)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisuride alone (1.43 +/- 0.10 mg)
Trial: 6195911
Drug: Propranolol, 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol, 40 mg every 8 hours
Trial: 6195911
Drug: Acebutolol, 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acebutolol, 300 mg every 8 hours
Trial: 28952704
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with 5-reductase inhibitors and blockers
Trial: 17496655
Drug: Bilateral cochlear
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral cochlear implants
Trial: 18580613
Drug: Immediate antiretroviral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate antiretroviral therapy (ART)
Trial: 25765099
Drug: rhGH +
RxNorm normalized name: rhGH
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhGH + 150 rhIGF-1 (45/150 µg/kg)
Trial: 12782545
Drug: 200 mg/day
RxNorm normalized name: alpelisib 200 mg/day (200 mg x 1) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg/day oral androstenedione
Trial: 3792426
Drug: Cimetidine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (300 mg every 6 h)
Trial: 3792426
Drug: Ranitidine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (150 mg every 12 h)
Trial: 31567714
Drug: 100 mL
RxNorm normalized name: PVC IV Bag 100 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mL isotonic saline (control group)
Trial: 20433527
Drug: Lactotripeptides dosed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactotripeptides dosed twice daily
Trial: 20433527
Drug: Lactotripeptides in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactotripeptides in treatment-naive patients
Trial: 20433527
Drug: Placebo in
RxNorm normalized name: placebo INTRAVEN VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo in treatment-naive patients
Trial: 12390641
Drug: Children's ibuprofen
RxNorm normalized name: Children's Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Children's ibuprofen suspension (7.5 mg/kg, p.o.)
Trial: 797088
Drug: Vistarin injections
RxNorm normalized name: Vistaril Injectable Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vistarin injections
Trial: 797088
Drug: Varicocide injections
RxNorm normalized name: AESCULUS CHINENSIS WHOLE 4 g in 100 g / ARNICA CORDIFOLIA WHOLE 3 g in 100 g TOPICAL PATCH [Rotosxika Varicoce Veins Plaster]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varicocide injections
Trial: 16533414
Drug: Pulsed-dose oxygen-conserving
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed-dose oxygen-conserving device (PDOCD)
Trial: 16533414
Drug: Pulsed-dose oxygen-conserving
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed-dose oxygen-conserving device (PDOCD) with sensitive triggering sensitivity
Trial: 12648029
Drug: Ritalin LA
RxNorm normalized name: Ritalin LA
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ritalin LA 20 mg capsule
Trial: 12648029
Drug: Concerta 18
RxNorm normalized name: Concerta 18mg Extended-Release Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concerta 18 mg tablet
Trial: 11197318
Drug: Active nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Active nicotine patch (21 mg for 6 weeks, then 14 mg for weeks 7-8, and 7 mg for weeks 9-10)
Trial: 17641254
Drug: Topiramate 400
RxNorm normalized name: topiramate 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate 400 mg/day